Ling Xu Selected Research

Ling Xu Research Topics

Disease

165	Neoplasms (Cancer) 12/2022 - 09/2003
63	Breast Neoplasms (Breast Cancer) 08/2022 - 03/2009
53	Stomach Neoplasms (Stomach Cancer) 11/2021 - 02/2005
28	Neoplasm Metastasis (Metastasis) 11/2022 - 02/2005
27	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2003
26	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 11/2011
25	Infections 05/2022 - 04/2005
22	Hepatocellular Carcinoma (Hepatoma) 05/2020 - 01/2012
21	Leukemia 01/2022 - 07/2009
18	Osteoporosis 05/2022 - 06/2003
17	Carcinogenesis 11/2022 - 12/2011
16	Carcinoma (Carcinomatosis) 01/2021 - 02/2005
15	Inflammation (Inflammations) 02/2022 - 03/2012
11	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2022 - 02/2011
11	Lymphoma (Lymphomas) 01/2022 - 03/2009
10	Pain (Aches) 03/2022 - 09/2007
9	Dry Eye Syndromes (Dry Eye Syndrome) 03/2022 - 07/2020
9	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2021 - 09/2009
8	Colorectal Neoplasms (Colorectal Cancer) 07/2021 - 09/2011
8	Disease Progression 05/2021 - 11/2006
7	Atherosclerosis 12/2021 - 06/2016
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2021 - 01/2015
7	Liver Neoplasms (Liver Cancer) 01/2020 - 12/2011
6	COVID-19 11/2022 - 05/2020
6	Wounds and Injuries (Trauma) 01/2021 - 01/2010
6	Liver Cirrhosis (Hepatic Cirrhosis) 01/2021 - 01/2014
6	Hypoxia (Hypoxemia) 01/2021 - 03/2005
6	Fatigue 01/2020 - 03/2012
6	Necrosis 01/2020 - 11/2012
6	Fibrosis (Cirrhosis) 01/2019 - 01/2012
6	Cancer Pain 07/2015 - 09/2007
5	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2022 - 10/2012
5	Adenocarcinoma of Lung 03/2021 - 09/2003
5	Diabetic Nephropathies (Diabetic Nephropathy) 01/2020 - 05/2008
5	Melanoma (Melanoma, Malignant) 10/2019 - 12/2008
5	Type 2 Diabetes Mellitus (MODY) 06/2019 - 10/2014
5	Bone Resorption 01/2018 - 09/2009
5	Pancreatic Neoplasms (Pancreatic Cancer) 07/2015 - 01/2009
4	Insulin Resistance 08/2022 - 01/2019
4	Triple Negative Breast Neoplasms 04/2022 - 12/2014

Drug/Important Bio-Agent (IBA)

49	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2003
30	Biomarkers (Surrogate Marker)IBA 08/2022 - 01/2013
25	Pharmaceutical PreparationsIBA 01/2022 - 09/2008
21	MicroRNAs (MicroRNA)IBA 08/2022 - 09/2009
21	Messenger RNA (mRNA)IBA 01/2022 - 03/2005
21	LigandsIBA 01/2020 - 03/2009
19	LipidsIBA 05/2022 - 05/2007
18	CytokinesIBA 01/2022 - 08/2004
15	Biological ProductsIBA 01/2022 - 02/2005
14	DNA (Deoxyribonucleic Acid)IBA 09/2021 - 09/2003
13	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020 - 11/2006
10	ErbB Receptors (EGF Receptor)IBA 11/2022 - 01/2013
10	VaccinesIBA 01/2022 - 11/2002
10	AntibodiesIBA 01/2022 - 11/2005
10	RNA (Ribonucleic Acid)IBA 10/2021 - 09/2003
9	Insulin (Novolin)FDA Link 08/2022 - 05/2007
9	Antiviral Agents (Antivirals)IBA 04/2022 - 11/2016
9	Hormones (Hormone)IBA 01/2022 - 09/2010
9	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 03/2009
8	Transcription Factors (Transcription Factor)IBA 12/2022 - 01/2009
8	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 08/2012
8	human ERBB2 proteinIBA 03/2022 - 12/2012
8	Fluorouracil (Carac)FDA LinkGeneric 10/2016 - 05/2006
7	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2022 - 04/2013
7	Indicators and Reagents (Reagents)IBA 01/2022 - 03/2011
7	Phenobarbital (Luminal)FDA Link 12/2021 - 02/2014
6	Carrier Proteins (Binding Protein)IBA 10/2022 - 09/2014
6	Trastuzumab (Herceptin)FDA Link 02/2022 - 12/2012
6	AntigensIBA 01/2021 - 04/2011
6	Long Noncoding RNAIBA 07/2020 - 09/2014
6	Epidermal Growth Factor (EGF)IBA 12/2019 - 11/2012
6	proanthocyanidinIBA 05/2019 - 05/2008
6	UbiquitinIBA 01/2018 - 07/2009
6	Therapeutic UsesIBA 01/2016 - 08/2004
6	Death Domain ReceptorsIBA 07/2014 - 03/2009
5	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
5	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2013
5	oxidized low density lipoproteinIBA 01/2022 - 06/2011
5	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 03/2015
5	Anti-Bacterial Agents (Antibiotics)IBA 12/2021 - 01/2012
5	CateninsIBA 11/2021 - 01/2013
5	CollagenIBA 01/2021 - 12/2011
5	Collagen Type I (Type I Collagen)IBA 01/2021 - 09/2009
5	Estrogens (Estrogen)FDA Link 08/2020 - 06/2009
5	elemeneIBA 04/2020 - 05/2011
5	Matrix Metalloproteinases (MMPs)IBA 04/2020 - 08/2004
5	Small Interfering RNA (siRNA)IBA 01/2020 - 01/2011
5	Cetuximab (Erbitux)FDA Link 01/2020 - 09/2013
5	Interleukin-6 (Interleukin 6)IBA 01/2020 - 01/2014
5	Concanavalin AIBA 12/2019 - 01/2013
5	AnthracyclinesIBA 03/2015 - 03/2009
4	ParaffinIBA 11/2022 - 01/2012
4	LipopolysaccharidesIBA 02/2022 - 01/2018

Therapy/Procedure

80	Therapeutics 04/2022 - 06/2006
37	Drug Therapy (Chemotherapy) 12/2022 - 01/2008
24	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 09/2003
22	Neoadjuvant Therapy 08/2022 - 03/2009
15	Immunotherapy 08/2022 - 12/2008
6	Adjuvant Chemotherapy 04/2020 - 03/2010
5	Aftercare (After-Treatment) 01/2022 - 01/2013